Skip to main content
. Author manuscript; available in PMC: 2009 Mar 1.
Published in final edited form as: Peptides. 2007 Nov 21;29(3):440–447. doi: 10.1016/j.peptides.2007.11.005

Figure 3. Effects of ICV High Dose PG-932 Infusion.

Figure 3

Infusion of 0.5 μg/hr of peptide PG-932 vs. saline. (A) Weight Gain: PG-932 caused significant increases in cumulative weight gain (p < 0.0001) and (B) Food Intake: PG-932 resulted in a significant increase in cumulative food intake (p < 0.0001)(n = 10/group).